Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters at The Pearl innovation district in midtown ...
New York invests $65M in biotech with new clinical trial consortium and Biogenesis Park to compete with Boston, San Francisco ...
John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...
China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...
The rapid development of China's RAS-targeted cancer drugs could reshape global oncology and unlock the country's undervalued ...
US biotech major Regeneron Pharmaceuticals on May 25 announced a global capability centre (GCC) in Hyderabad, expanding its India footprint. The facility, expected to go live in the second half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results